AI-Driven De Novo Generation of Protein Binders

Format:

AI-Driven De Novo Generation of Protein Binders

About the poster

This project aimed to leverage AI-driven methods, complemented by advanced computational techniques such as Molecular Modelling (MM) and Molecular Dynamics (MD) simulations, to generate novel binders for two prespecified protein targets: T1 and T2. The entire binder discovery process – from initial target analysis to final candidate selection – was performed in silico.

The core objective was to generate a ranked list of up to 100 binder candidates for each target through a comprehensive computational approach. This process encompasses the identification of promising binding sites, the design of novel binder structures and sequences using generative AI models, and rigorous in silico filtering and ranking based on predicted binding, stability, solubility, and other key biochemical properties. 

Poster was presented at PEGS 2026 in Boston

You might be also interested in:

Webinar: Lab-in-the-Loop: reclaiming the 50% of scientific time lost to data
Lab-in-the-Loop: reclaiming the 50% of scientific time lost to data
Blog cover for Ardigen publication on ARDisplay-I and MHC ligand identification in Molecular & Cellular Proteomics
New publication in MCP: Improving MHC ligand identification with machine learning and optimized isolation
Fluorescence microscopy image of cells stained with multiple Cell Painting dyes showing cellular organelles in green, blue, and pink, overlaid with Ardigen brand graphic elements indicating phenomics data in durg discovery
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Abstract network visualization representing AI-driven integration of biological data and knowledge graphs for target identification in drug discovery.
Target Identification: From Poor Data to Quality Predictions

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!